Abnormalities of the nucleus basalis in Down's syndrome
- PMID: 2932050
- DOI: 10.1002/ana.410180306
Abnormalities of the nucleus basalis in Down's syndrome
Abstract
One of the most striking manifestations of Down's syndrome is profound mental retardation. Furthermore, after 35 years of age, many patients with Down's syndrome develop clinical and pathological features of Alzheimer's disease. Since brains of patients with Alzheimer's disease show significant loss of neurons in the nucleus basalis of Meynert (nbM), we sought to establish normal standards of nbM neurons in persons with Down's syndrome and to determine whether reductions in the number of neurons occur with increasing age. The number and size of neurons in the nbM were measured in selected sagittal sections from 5 patients with Down's syndrome and 5 age-matched controls. The patients (age range, 16 to 56 years) had 29% fewer nbM neurons than controls, and the oldest patient had the lowest cell count of all subjects. The size of nbM neurons did not differ significantly between the two groups. Our results show that the nbM contains fewer neurons in young persons with Down's syndrome than in normal controls and suggest that the number of these nerve cells may be further reduced in older persons with Down's syndrome.
Similar articles
-
The nucleus basalis of Meynert in neurological disease: a quantitative morphological study.Ann Neurol. 1985 Feb;17(2):163-70. doi: 10.1002/ana.410170210. Ann Neurol. 1985. PMID: 3883886
-
Age-related cortical grey matter reductions in non-demented Down's syndrome adults determined by MRI with voxel-based morphometry.Brain. 2004 Apr;127(Pt 4):811-24. doi: 10.1093/brain/awh101. Epub 2004 Feb 25. Brain. 2004. PMID: 14985261
-
Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease.N Engl J Med. 1989 Jun 1;320(22):1446-52. doi: 10.1056/NEJM198906013202203. N Engl J Med. 1989. PMID: 2566117
-
Down's syndrome and Alzheimer's dementia: defining an association.Psychiatr Dev. 1984 Winter;2(4):287-94. Psychiatr Dev. 1984. PMID: 6241313 Review.
-
[Alzheimer's disease and Down's syndrome: a review].Riv Neurol. 1990 Jul-Aug;60(4):151-9. Riv Neurol. 1990. PMID: 2151240 Review. Italian.
Cited by
-
Prospects for improving brain function in individuals with Down syndrome.CNS Drugs. 2013 Sep;27(9):679-702. doi: 10.1007/s40263-013-0089-3. CNS Drugs. 2013. PMID: 23821040 Review.
-
Sex differences in the cholinergic basal forebrain in the Ts65Dn mouse model of Down syndrome and Alzheimer's disease.Brain Pathol. 2014 Jan;24(1):33-44. doi: 10.1111/bpa.12073. Epub 2013 Jul 19. Brain Pathol. 2014. PMID: 23802663 Free PMC article.
-
Cystatin C prevents neuronal loss and behavioral deficits via the endosomal pathway in a mouse model of down syndrome.Neurobiol Dis. 2018 Dec;120:165-173. doi: 10.1016/j.nbd.2018.08.025. Epub 2018 Sep 1. Neurobiol Dis. 2018. PMID: 30176349 Free PMC article.
-
Excitatory-inhibitory relationship in the fascia dentata in the Ts65Dn mouse model of Down syndrome.J Comp Neurol. 2009 Feb 1;512(4):453-66. doi: 10.1002/cne.21895. J Comp Neurol. 2009. PMID: 19034952 Free PMC article.
-
The Link between Alzheimer's Disease and Down Syndrome. A Historical Perspective.Curr Alzheimer Res. 2016;13(1):2-6. doi: 10.2174/1567205012999151021102914. Curr Alzheimer Res. 2016. PMID: 26487155 Free PMC article. No abstract available.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical